Drug intelligence / Profile preview

mucopolysaccharide polysulfate + glucocorticoids

Development stage
Unknown
Lead developer
Maruho
Modality
Small Molecules
Administration
Topical
01

Overview

This is a combination therapy involving mucopolysaccharide polysulfate (MPS) and topical glucocorticoids. Mucopolysaccharide polysulfate is an anti-inflammatory and anticoagulant agent, commonly used for the treatment of bruising, varicose veins, and superficial thrombophlebitis. It also acts as a moisturizer to improve skin barrier function in conditions like xerosis and atopic dermatitis[2][6]. Glucocorticoids are steroid hormones with potent anti-inflammatory and immunosuppressive properties, widely used in dermatology for their ability to reduce inflammation in various skin disorders. The combination of MPS with topical corticosteroids has been shown to mitigate some adverse effects associated with long-term steroid use—such as skin barrier impairment—by improving tight junction (TJ) barrier function through upregulation of claudin-1 expression in keratinocytes[1][3]. This may help delay relapses in atopic dermatitis when both agents are used together.

Brand names
Hirudoid (for mucopolysaccharide polysulfate)
Other names
MPS + glucocorticoidsheparinoid + glucocorticoids
02

Targets

GR (Glucocorticoid receptor)TEK (Tie2)

Beyond the preview

Go deeper on mucopolysaccharide polysulfate + glucocorticoids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mucopolysaccharide polysulfate + glucocorticoids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call